A migraine headache can easily bring someone's usual day to a halt. The intense throbbing pain, usually on one side of the ...

The American Academy of Neurology (AAN) and American Headache Society (AHS) issued an updated practice guideline for the ...

CT-132 statistically significantly reduced monthly migraine days compared with sham digital treatment after 12 weeks. The Food and Drug Administration (FDA) has granted marketing authorization to ...

Migraine treatments fall into two groups: acute options to stop pain fast, and preventive options to reduce attacks. The right plan can mean fewer episodes and less severe pain. Acute treatment works ...

Migraine is a complex neurological disease that affects about 1 billion people globally. It is associated with a variety of symptoms that can vary widely from person to person, and even from attack to ...

Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines. The de novo ...

SAN DIEGO — An adjunctive, first-in-class investigational prescription digital therapeutic significantly reduced monthly migraine days (MMDs) in patients with episodic migraine (EM) compared with sham ...

The National Pharmaceutical Association (NPhA), with support from Pfizer, has launched a new migraine toolkit aimed at helping community pharmacists address long-standing racial d ...

SAN DIEGO — ChatGPT, an artificial intelligence (AI) tool that can provide headache information, makes significant errors regarding migraine drug treatments but does better when it comes to ...

The use of migraine medications in workers’ compensation prescriptions, despite the overall cost per claim decreasing, a new report shows. The first part of Enlyte’s 2025 Drug Trends Report released ...